Drug Profile
Research programme: antifungal drug conjugate - Centrose
Latest Information Update: 01 Aug 2016
Price :
$50
*
At a glance
- Originator Wisconsin Alumni Research Foundation
- Developer Centrose
- Class Antifungals; Cardiac glycosides; Drug conjugates; Immunoconjugates
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 01 Aug 2016 No recent reports on development identified for Mycoses in USA (Transdermal)